FDA Approves Ensitrelvir to Prevent COVID-19 After Exposure - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

FDA Approves Ensitrelvir to Prevent COVID-19 After Exposure

Phase 3 data showed a 67% reduction in symptomatic infection among exposed household contacts who tested negative at baseline.

  • By

  • Kathryn Wighton

  • June 2, 2026

  • 3 min

Share

Original Source(s)

FDA Approves Ensitrelvir to Prevent COVID-19 After Exposure

  • by Kathryn Wighton

  • June 2, 2026

Related Content

Top 10 CDC Updates Physicians Should Know

Recent CDC advisories, testing updates, and immunization recommendations highlight developments in infectious diseases, immunization, and diagnostic testing relevant to physicians across multiple specialties.

ACIP, MMRV, and Vaccine Equity—What the September 2025 Vote Did Not Ask

Conformational bias in SARS-CoV-2 Spike CD4+ T-cell epitope dominance